UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship between overall survival and time to progression after transarterial chemoembolization therapy in patients with hepatocellular carcinoma

Journal of hepatology, 2017, Vol.66 (1), p.S620-S620

2017

Volltextzugriff (PDF)

Early Detection and Curative Treatment of Early-Stage Hepatocellular Carcinoma

Clinical gastroenterology and hepatology, 2005-10, Vol.3 (10 Suppl 2), p.S144-S148

Kudo, Masatoshi

2005

Volltextzugriff (PDF)

Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart

Journal of molecular and cellular cardiology, 2003-09, Vol.35 (9), p.1113-1119

2003

Volltextzugriff (PDF)

Effects of hydrogen on film properties of diamond-like carbon films prepared by reactive radio-frequency magnetron sputtering using hydrogen gas

Thin solid films, 2005-09, Vol.488 (1), p.87-92

2005

Volltextzugriff (PDF)

Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational study

Journal of hepatology, 2017, Vol.66 (1), p.S223-S224

2017

Volltextzugriff (PDF)

The Epoch Method of Defect Re-Purfusion Imaging to Diagnose Small Hepatocellular Carcinoma With New Second Contrast Agent Sonazoid

Ultrasound in medicine & biology, 2013-05, Vol.39 (5), p.S27-S28

2013

Volltextzugriff (PDF)

P1338 : An international observational study to assess the use of sorafenib after transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC): optimis

Journal of hepatology, 2015-04, Vol.62, p.S858-S858

2015

Volltextzugriff (PDF)

P0383 : Combined sequential use of HAP and ART scores to predict transarterial chemoembolization failure in hepatocellular carcinoma: A multi-center comparative study

Journal of hepatology, 2015-04, Vol.62, p.S456-S456

2015

Volltextzugriff (PDF)

Integration of the Cancer-Related Pro-Inflammatory Response as a Stratifying Biomarker of Survival Benefit with Sorafenib in Hepatocellular Carcinoma

Journal of hepatology, 2016, Vol.64 (2), p.S195-S195

2016

Volltextzugriff (PDF)

689 THE DECREASE OF BLOOD FLOW AFTER ADMINISTRATION OF SORAFENIB MAY IMPROVE OVERALL SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2012-04, Vol.56, p.S273-S273

2012

Volltextzugriff (PDF)

Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study

Journal of hepatology, 2017, Vol.66 (1), p.S34-S35

2017

Volltextzugriff (PDF)

An Objective Model to Optimize Treatment Decisions in Advanced Hepatocellular Carcinoma after Sorafenib Failure: The Sorfa Score

Journal of hepatology, 2016, Vol.64 (2), p.S690-S690

2016

Volltextzugriff (PDF)

Structural changes of diamond-like carbon films due to atomic hydrogen exposure during annealing

Applied surface science, 2007-02, Vol.253 (9), p.4188-4196

2007

Volltextzugriff (PDF)

The ALBI Grade Provides Objective Hepatic Reserve Phenotyping across Each BCLC Stage of Hepatocellular Carcinoma

Journal of hepatology, 2016, Vol.64 (2), p.S196-S196

2016

Volltextzugriff (PDF)

2094 Randomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type metastatic colorectal cancer: HGCSG1001 (Japanese Skin Toxicity Evaluation Protocol With Panitumumab: J-STEPP): Updated analysis of anti-tumor efficacy

European journal of cancer (1990), 2015-09, Vol.51, p.S359-S359

2015

Volltextzugriff (PDF)

2092 Updated analysis: Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin(OX)+BV and oral FU/OX+BV

European journal of cancer (1990), 2015-09, Vol.51, p.S358-S359

2015

Volltextzugriff (PDF)

2096 Phase II trial of Irinotecan plus S-1 (IRIS) with Cetuximab (IRIS/Cet) in pre-treated patients with KRAS wild type of metastatic colorectal cancer (mCRC): HGCSG0902 updated analysis

European journal of cancer (1990), 2015-09, Vol.51, p.S360-S360

2015

Volltextzugriff (PDF)

Prospective Randomized Controlled Phase III Trial Comparing the Efficacy of Sorafenib versus Sorafenib in Combination with Low-Dose Cisplatin/Fluorouracil Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma

Journal of hepatology, 2016, Vol.64 (2), p.S209-S210

2016

Volltextzugriff (PDF)

G06 : A randomized, double-blind, placebo-controlled phase III trial of TSU-68 (orantinib) combined with transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma

Journal of hepatology, 2015-04, Vol.62, p.S189-S190

2015

Volltextzugriff (PDF)

2337 Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment

European journal of cancer (1990), 2015-09, Vol.51, p.S446-S446

2015

Volltextzugriff (PDF)

P933 ONCE-DAILY ORAL LUSUTROMBOPAG, ALTERNATIVE TO PLATELET TRANSFUSION IN THROMBOCYTOPENIC PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING RADIOFREQUENCY ABLATION: RESULTS FROM A PHASE 2B, RANDOMIZED, DOUBLE-BLIND STUDY

Journal of hepatology, 2014-04, Vol.60 (1), p.S386-S386

2014

Volltextzugriff (PDF)

Ramucirumab as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Analysis of Reach Patients by Albumin-Bilirubin (ALBI) Grade

Journal of hepatology, 2016, Vol.64 (2), p.S693-S694

2016

Volltextzugriff (PDF)

P0372 : Gideon: A retrospective analysis of prognostic factors for survival

Journal of hepatology, 2015-04, Vol.62, p.S451-S452

2015

Volltextzugriff (PDF)

P551 EVALUATION OF ART SCORE FOR REPEATED TRANSARTERIAL CHEMOEMBOLIZATION IN JAPANESE COHORT OF HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2014-04, Vol.60 (1), p.S253-S253

2014

Volltextzugriff (PDF)

PHP107 Observations of Hepatocellular Carcinoma (HCC) Management Patterns from the Global HCC Bridge Study: An Interim Analysis of HCC Burden of Illness in the Asia-Pacific (AP) Cohort

Value in health, 2012-11, Vol.15 (7), p.A626-A626

2012

Volltextzugriff (PDF)

1 – 25 von 1.405

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnnals Of Oncology

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.376)
Mit Volltextzugriff
(1.360)

Publikationsform

Sprache

Englisch
(1.398)
Japanisch
(331)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(875)
Life Sciences & Biomedicine
(587)
Humans
(391)
Biological And Medical Sciences
(300)
Animals
(259)
Male
(259)
Female
(258)
Physical Sciences
(245)
Technology
(210)
Physics
(203)
Medical Sciences
(174)
Exact Sciences And Technology
(173)
Chemistry
(143)
Fundamental And Applied Biological Sciences. Psychology
(143)
Middle Aged
(136)
Aged
(118)
Adult
(114)
Neurosciences & Neurology
(112)
Rats
(108)
Biochemistry & Molecular Biology
(106)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Relationship between overall survival and time to progression after transarterial chemoembolization therapy in patients with hepatocellular carcinoma

Early Detection and Curative Treatment of Early-Stage Hepatocellular Carcinoma

Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart

Effects of hydrogen on film properties of diamond-like carbon films prepared by reactive radio-frequency magnetron sputtering using hydrogen gas

Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational study

The Epoch Method of Defect Re-Purfusion Imaging to Diagnose Small Hepatocellular Carcinoma With New Second Contrast Agent Sonazoid

P1338 : An international observational study to assess the use of sorafenib after transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC): optimis

P0383 : Combined sequential use of HAP and ART scores to predict transarterial chemoembolization failure in hepatocellular carcinoma: A multi-center comparative study

Integration of the Cancer-Related Pro-Inflammatory Response as a Stratifying Biomarker of Survival Benefit with Sorafenib in Hepatocellular Carcinoma

689 THE DECREASE OF BLOOD FLOW AFTER ADMINISTRATION OF SORAFENIB MAY IMPROVE OVERALL SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study

An Objective Model to Optimize Treatment Decisions in Advanced Hepatocellular Carcinoma after Sorafenib Failure: The Sorfa Score

Structural changes of diamond-like carbon films due to atomic hydrogen exposure during annealing

The ALBI Grade Provides Objective Hepatic Reserve Phenotyping across Each BCLC Stage of Hepatocellular Carcinoma

2094 Randomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type metastatic colorectal cancer: HGCSG1001 (Japanese Skin Toxicity Evaluation Protocol With Panitumumab: J-STEPP): Updated analysis of anti-tumor efficacy

2092 Updated analysis: Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin(OX)+BV and oral FU/OX+BV

2096 Phase II trial of Irinotecan plus S-1 (IRIS) with Cetuximab (IRIS/Cet) in pre-treated patients with KRAS wild type of metastatic colorectal cancer (mCRC): HGCSG0902 updated analysis

Prospective Randomized Controlled Phase III Trial Comparing the Efficacy of Sorafenib versus Sorafenib in Combination with Low-Dose Cisplatin/Fluorouracil Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma

G06 : A randomized, double-blind, placebo-controlled phase III trial of TSU-68 (orantinib) combined with transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma

2337 Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment

P933 ONCE-DAILY ORAL LUSUTROMBOPAG, ALTERNATIVE TO PLATELET TRANSFUSION IN THROMBOCYTOPENIC PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING RADIOFREQUENCY ABLATION: RESULTS FROM A PHASE 2B, RANDOMIZED, DOUBLE-BLIND STUDY

Ramucirumab as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Analysis of Reach Patients by Albumin-Bilirubin (ALBI) Grade

P0372 : Gideon: A retrospective analysis of prognostic factors for survival

P551 EVALUATION OF ART SCORE FOR REPEATED TRANSARTERIAL CHEMOEMBOLIZATION IN JAPANESE COHORT OF HEPATOCELLULAR CARCINOMA

PHP107 Observations of Hepatocellular Carcinoma (HCC) Management Patterns from the Global HCC Bridge Study: An Interim Analysis of HCC Burden of Illness in the Asia-Pacific (AP) Cohort

Aktive Filter

Suchergebnisse filtern